Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 61,200
- Value
- $11.6M
- % of portfolio
- 0.5%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 61,200 | $11.6M | 0.5% | −7,719−11.2% | Reduced | Holders |
| Q1 2026 | 68,919 | $13.6M | 0.7% | +1,117+1.6% | AddedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 135,605 | $12.5M | 0.6% | −623−0.5% | Reduced | Holders |
| Q3 2025 | 136,228 | $10.5M | 0.5% | +120,577+770.4% | Added | Holders |
| Q2 2025 | 15,651 | $1.09M | 0.1% | −1,144−6.8% | Reduced | Holders |
| Q1 2025 | 16,795 | $1.23M | 0.1% | +622+3.8% | Added | Holders |
| Q4 2024 | 16,173 | $1.06M | 0.1% | +15+0.1% | Added | Holders |
| Q3 2024 | 16,158 | $1.26M | 0.1% | +162+1.0% | Added | Holders |
| Q2 2024 | 15,996 | $1.25M | 0.1% | +168+1.1% | Added | Holders |
| Q1 2024 | 15,828 | $1.07M | 0.1% | −7,129−31.1% | Reduced | Holders |
| Q4 2023 | 22,957 | $1.55M | 0.1% | −419−1.8% | Reduced | Holders |
| Q3 2023 | 23,376 | $1.58M | 0.1% | +23,376 | New | Holders |